Certified by Founder Lodge
Enara Bio
United Kingdom - Oxford, Oxfordshire
START UP
1 Disclosed Funding Rounds $32,500,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Enara Bio is shining a light on Dark Antigen® and T-cell biology to develop cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients. Our pioneer
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 04 ,2024 | Series B | $32,500,000 |
SV Health Investors
Pfizer
RA Capital Management, L.P.
Samsara BioCapital
M Ventures(Netherlands)
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
